Grail (GRAL) Asset Writedowns and Impairment (2023 - 2026)
Grail's (GRAL) quarterly Asset Writedowns and Impairment came in at $25.4 million in Q2 2026, down 9.2% on a YoY basis from $28.0 million in Q2 2025, and up 10192.71% quarter-over-quarter from $247000.0 in Q1 2026.
Analysis
Grail (GRAL) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Asset Writedowns and Impairment for 4 consecutive years, with $25.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Writedowns and Impairment fell 9.2% year-over-year to $25.4 million; the trailing twelve-month figure through Jun 2026 stood at $25.7 million (down 9.21% YoY), and the FY2025 full-year result was $28.0 million, down 98.03% from the prior year.
- Asset Writedowns and Impairment climbed to $25.4 million in Q2 2026 per GRAL's latest filing, from $247000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.4 billion in Q2 2024 and bottomed at $247000.0 in Q1 2026.
- Historically, Asset Writedowns and Impairment has averaged $365.6 million across 4 years, with a median of $26.7 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Asset Writedowns and Impairment tumbled 98.03% in 2025, then dropped 9.2% in 2026.
- Over 4 years, Asset Writedowns and Impairment stood at $718.5 million in 2023, then jumped by 97.77% to $1.4 billion in 2024, then sank by 98.03% to $28.0 million in 2025, then decreased by 9.2% to $25.4 million in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $25.4 million, $247000.0, and $28.0 million for Q2 2026, Q1 2026, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.42 Mn |
| Mar 31, 2026 | 247,000.00 |
| Jun 30, 2025 | 28.00 Mn |
| Mar 31, 2025 | 273,000.00 |
| Jun 30, 2024 | 1.42 Bn |
| Oct 1, 2023 | 718.47 Mn |